BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morís G. Inflammatory bowel disease: An increased risk factor for neurologic complications. World J Gastroenterol 2014; 20(5): 1228-1237 [PMID: 24574797 DOI: 10.3748/wjg.v20.i5.1228] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 41] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Yang Y, Zhang Y. Acute transverse myelitis in an adult-patient with underlying ulcerative colitis: a case report. BMC Gastroenterol 2022;22:161. [PMID: 35365068 DOI: 10.1186/s12876-022-02230-z] [Reference Citation Analysis]
2 Nemati R, Mehdizadeh S, Salimipour H, Yaghoubi E, Alipour Z, Tabib SM, Assadi M. Neurological manifestations related to Crohn's disease: a boon for the workforce. Gastroenterol Rep (Oxf) 2019;7:291-7. [PMID: 31413837 DOI: 10.1093/gastro/gox034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
3 Dolapcioglu C, Dolapcioglu H. Structural brain lesions in inflammatory bowel disease. World J Gastrointest Pathophysiol 2015; 6(4): 124-130 [PMID: 26600970 DOI: 10.4291/wjgp.v6.i4.124] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
4 Karmiris K, Bossuyt P, Sorrentino D, Moreels T, Scarcelli A, Legido J, Dotan I, Naismith GD, Jussila A, Preiss JC, Kruis W, Li ACY, Bouguen G, Yanai H, Steinwurz F, Katsanos KH, Subramaniam K, Tarabar D, Zaganas IV, Ben-horin S; ECCO CONFER investigators. Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents. Journal of Crohn's and Colitis 2015;9:382-9. [DOI: 10.1093/ecco-jcc/jjv042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
5 Li L, Ma J, Xu JG, Zheng YL, Xie Q, Rong L, Liang ZH. Brain functional changes in patients with Crohn's disease: A resting-state fMRI study. Brain Behav 2021;11:e2243. [PMID: 34124857 DOI: 10.1002/brb3.2243] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Vojdani A, Vojdani E, Herbert M, Kharrazian D. Correlation between Antibodies to Bacterial Lipopolysaccharides and Barrier Proteins in Sera Positive for ASCA and ANCA. Int J Mol Sci 2020;21:E1381. [PMID: 32085663 DOI: 10.3390/ijms21041381] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
7 Gondim FDAA, de Oliveira GR, Teles BCV, Aquino PDS, Brasil ÉF, Carvalho AM, Souza MHLP, Braga LLBC, Rola FH. Clinical and Electrodiagnostic Findings in Patients with Peripheral Neuropathy and Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 2015;21:2123-9. [DOI: 10.1097/mib.0000000000000459] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Cançado GGL, Vilela EG. Guillain–Barré syndrome during adalimumab therapy for Crohn´s disease: coincidence or consequence? Scandinavian Journal of Gastroenterology 2017;52:473-6. [DOI: 10.1080/00365521.2016.1263682] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Ślebioda TJ, Kmieć Z. Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease. Mediators Inflamm 2014;2014:325129. [PMID: 25045210 DOI: 10.1155/2014/325129] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 6.9] [Reference Citation Analysis]
10 Lv K, Fan YH, Xu L, Xu MS. Brain changes detected by functional magnetic resonance imaging and spectroscopy in patients with Crohn's disease. World J Gastroenterol 2017; 23(20): 3607-3614 [PMID: 28611513 DOI: 10.3748/wjg.v23.i20.3607] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
11 Camara-Lemarroy CR, Metz L, Meddings JB, Sharkey KA, Wee Yong V. The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics. Brain. 2018;141:1900-1916. [PMID: 29860380 DOI: 10.1093/brain/awy131] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 16.7] [Reference Citation Analysis]
12 De Caro C, Leo A, Nesci V, Ghelardini C, di Cesare Mannelli L, Striano P, Avagliano C, Calignano A, Mainardi P, Constanti A, Citraro R, De Sarro G, Russo E. Intestinal inflammation increases convulsant activity and reduces antiepileptic drug efficacy in a mouse model of epilepsy. Sci Rep 2019;9:13983. [PMID: 31562378 DOI: 10.1038/s41598-019-50542-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
13 Gekka M, Sugiyama T, Nomura M, Kato Y, Nishihara H, Asaoka K. Histologically confirmed case of cerebral vasculitis associated with Crohn's disease--a case report. BMC Neurol 2015;15:169. [PMID: 26390922 DOI: 10.1186/s12883-015-0429-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
14 Iannone LF, Preda A, Blottière HM, Clarke G, Albani D, Belcastro V, Carotenuto M, Cattaneo A, Citraro R, Ferraris C, Ronchi F, Luongo G, Santocchi E, Guiducci L, Baldelli P, Iannetti P, Pedersen S, Petretto A, Provasi S, Selmer K, Spalice A, Tagliabue A, Verrotti A, Segata N, Zimmermann J, Minetti C, Mainardi P, Giordano C, Sisodiya S, Zara F, Russo E, Striano P. Microbiota-gut brain axis involvement in neuropsychiatric disorders. Expert Rev Neurother 2019;19:1037-50. [PMID: 31260640 DOI: 10.1080/14737175.2019.1638763] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 14.3] [Reference Citation Analysis]
15 Zawadka-Kunikowska M, Słomko J, Kłopocka M, Liebert A, Tafil-Klawe M, Klawe JJ, Newton JL, Zalewski P. Cardiac and autonomic function in patients with Crohn's disease during remission. Adv Med Sci 2018;63:334-40. [PMID: 30053718 DOI: 10.1016/j.advms.2018.04.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Thomann AK, Thomann PA, Wolf RC, Hirjak D, Schmahl C, Ebert MP, Szabo K, Reindl W, Griebe M. Altered Markers of Brain Development in Crohn's Disease with Extraintestinal Manifestations - A Pilot Study. PLoS One 2016;11:e0163202. [PMID: 27655165 DOI: 10.1371/journal.pone.0163202] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
17 Drury J, Hickman SJ. Internuclear ophthalmoplegia associated with anti-TNFα medication. Strabismus 2015;23:30-2. [PMID: 25790247 DOI: 10.3109/09273972.2014.999796] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
18 Khan F, Seyam M, Sharma N, Ud Din M, Bansal V. New Horizons for Diagnostic Pitfalls of Cerebral Venous Thrombosis: Clinical Utility of a Newly Developed Cerebral Venous Thrombosis Diagnostic Score: A Case Report and Literature Review. Am J Case Rep 2021;22:e932123. [PMID: 34224551 DOI: 10.12659/AJCR.932123] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Defilippis EM, Barfield E, Leifer D, Steinlauf A, Bosworth BP, Scherl EJ, Sockolow R. Cerebral venous thrombosis in inflammatory bowel disease: Cerebral venous thrombosis in IBD. Journal of Digestive Diseases 2015;16:104-8. [DOI: 10.1111/1751-2980.12212] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
20 Pfeiffer RF. Gastroenterology and Neurology. Continuum (Minneap Minn) 2017;23:744-61. [PMID: 28570327 DOI: 10.1212/CON.0000000000000484] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
21 Lee G. Acute longitudinal extensive transverse myelitis secondary to asymptomatic SARS-CoV-2 infection. BMJ Case Rep 2021;14:e244687. [PMID: 34226258 DOI: 10.1136/bcr-2021-244687] [Reference Citation Analysis]
22 Parikh A, Stephens K, Major E, Fox I, Milch C, Sankoh S, Lev MH, Provenzale JM, Shick J, Patti M, McAuliffe M, Berger JR, Clifford DB. A Programme for Risk Assessment and Minimisation of Progressive Multifocal Leukoencephalopathy Developed for Vedolizumab Clinical Trials. Drug Saf 2018;41:807-16. [PMID: 29737503 DOI: 10.1007/s40264-018-0669-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
23 Raymond SB, Gee MS, Anupindi SA, Shailam R, Kaplan JL, Nimkin K. CT and MRI of Rare Extraintestinal Manifestations of Inflammatory Bowel Disease in Children and Adolescents. J Pediatr Gastroenterol Nutr 2016;63:e1-9. [PMID: 27050046 DOI: 10.1097/MPG.0000000000001225] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
24 Gallagher K, Catesson A, Griffin JL, Holmes E, Williams HRT. Metabolomic Analysis in Inflammatory Bowel Disease: A Systematic Review. J Crohns Colitis 2021;15:813-26. [PMID: 33175138 DOI: 10.1093/ecco-jcc/jjaa227] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, Burisch J, Gecse KB, Hart AL, Hindryckx P. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. J Crohns Colitis. 2017;11:649-670. [PMID: 28158501 DOI: 10.1093/ecco-jcc/jjx008] [Cited by in Crossref: 682] [Cited by in F6Publishing: 563] [Article Influence: 170.5] [Reference Citation Analysis]
26 Shapiro M, Blanco DA. Neurological Complications of Gastrointestinal Disease. Semin Pediatr Neurol 2017;24:43-53. [PMID: 28779865 DOI: 10.1016/j.spen.2017.02.001] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
27 Vosoughinia H, Latifnia M, Fattahi Abdizadeh M, Mokhtari Amirmajdi E, Ahadi M. The Relation Between Fecal Calprotectin and the Rate of Clinical Activity of Ulcerative Colitis. Razavi Int J Med 2018;6. [DOI: 10.5812/rijm.14533] [Reference Citation Analysis]
28 Fousekis FS, Katsanos AH, Kourtis G, Saridi M, Albani E, Katsanos KH, Christodoulou DK. Inflammatory Bowel Disease and Patients With Mental Disorders: What Do We Know? J Clin Med Res 2021;13:466-73. [PMID: 34691320 DOI: 10.14740/jocmr4593] [Reference Citation Analysis]
29 Parks PT, Easton AS. Cerebral Vasculitis in Ulcerative Colitis Is Predominantly Venular: Case Report and Review of the Literature. Case Rep Rheumatol 2019;2019:9563874. [PMID: 30937208 DOI: 10.1155/2019/9563874] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 De Andres C, García MI, Goicoechea H, Martínez-Ginés ML, García-Domínguez JM, Martín ML, Romero-Delgado F, Benguría A, Sanjurjo M, López-Fernández LA. Genes differentially expressed by methylprednisolone in vivo in CD4 T lymphocytes from multiple sclerosis patients: potential biomarkers. Pharmacogenomics J 2018;18:98-105. [PMID: 27670768 DOI: 10.1038/tpj.2016.71] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
31 Peter I, Dubinsky M, Bressman S, Park A, Lu C, Chen N, Wang A. Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease. JAMA Neurol 2018;75:939-46. [PMID: 29710331 DOI: 10.1001/jamaneurol.2018.0605] [Cited by in Crossref: 124] [Cited by in F6Publishing: 118] [Article Influence: 41.3] [Reference Citation Analysis]
32 Thomann AK, Reindl W, Wüstenberg T, Kmuche D, Ebert MP, Szabo K, Wolf RC, Hirjak D, Niesler B, Griebe M, Thomann PA. Aberrant brain structural large-scale connectome in Crohn's disease. Neurogastroenterol Motil 2019;31:e13593. [PMID: 30983094 DOI: 10.1111/nmo.13593] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
33 Martín-Masot R, Ortiz Pérez P, Serrano Nieto J, Martínez León M, Pascual Martínez A, Blasco-Alonso J, Navas-López VM. Central Venous Sinus Thrombosis in a Boy With Acute Severe Ulcerative Colitis. Front Pediatr 2019;7:19. [PMID: 30775357 DOI: 10.3389/fped.2019.00019] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
34 Lavie G, Zalmanovich A, Golan Y, Jonas Kimchi T, Barenboim E. Acute stroke revealing Takayasu's arteritis in a patient with Crohn's disease. Acta Clin Belg 2016;71:250-2. [PMID: 27075786 DOI: 10.1080/17843286.2015.1105604] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Li N, Wang XM, Jiang LJ, Zhang M, Li N, Wei ZZ, Zheng N, Zhao YJ. Effects of endoplasmic reticulum stress on the expression of inflammatory cytokines in patients with ulcerative colitis. World J Gastroenterol 2016; 22(7): 2357-2365 [PMID: 26900298 DOI: 10.3748/wjg.v22.i7.2357] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
36 Spagnoli C, Pisani F, Di Mario F, Leandro G, Gaiani F, De' Angelis GL, Fusco C. Peripheral neuropathy and gastroenterologic disorders: an overview on an underrecognized association. Acta Biomed 2018;89:22-32. [PMID: 30561392 DOI: 10.23750/abm.v89i9-S.7956] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
37 Di Giovangiulio M, Verheijden S, Bosmans G, Stakenborg N, Boeckxstaens GE, Matteoli G. The Neuromodulation of the Intestinal Immune System and Its Relevance in Inflammatory Bowel Disease. Front Immunol. 2015;6:590. [PMID: 26635804 DOI: 10.3389/fimmu.2015.00590] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
38 Abraham BP. Symptom management in inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology 2015;9:953-67. [DOI: 10.1586/17474124.2015.1038241] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
39 Roth B, Schiro DB, Ohlsson B. Diseases which cause generalized peripheral neuropathy: a systematic review. Scand J Gastroenterol 2021;56:1000-10. [PMID: 34214006 DOI: 10.1080/00365521.2021.1942542] [Reference Citation Analysis]
40 Citraro R, Lembo F, De Caro C, Tallarico M, Coretti L, Iannone LF, Leo A, Palumbo D, Cuomo M, Buommino E, Nesci V, Marascio N, Iannone M, Quirino A, Russo R, Calignano A, Constanti A, Russo E, De Sarro G. First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat. Epilepsia 2021;62:529-41. [PMID: 33428780 DOI: 10.1111/epi.16813] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
41 Wenzel TJ, Haskey N, Kwong E, Greuel BK, Gates EJ, Gibson DL, Klegeris A. Dietary fats modulate neuroinflammation in mucin 2 knock out mice model of spontaneous colitis. Biochim Biophys Acta Mol Basis Dis 2022;1868:166336. [PMID: 34973372 DOI: 10.1016/j.bbadis.2021.166336] [Reference Citation Analysis]
42 Shahmohammadi S, Sahraian MA, Shahmohammadi A, Doosti R, Zare-Mirzaie A, Naser Moghadasi A. A presentation of ulcerative colitis after rituximab therapy in a patient with multiple sclerosis and literature review. Mult Scler Relat Disord 2018;22:22-6. [PMID: 29524758 DOI: 10.1016/j.msard.2018.02.030] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
43 Coe CL, Horst SN, Izzy MJ. Neurologic Toxicities Associated with Tumor Necrosis Factor Inhibitors and Calcineurin Inhibitors. Neurol Clin 2020;38:937-51. [PMID: 33040870 DOI: 10.1016/j.ncl.2020.07.009] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 García-cabo C, Morís G. Peripheral neuropathy: An underreported neurologic manifestation of inflammatory bowel disease. European Journal of Internal Medicine 2015;26:468-75. [DOI: 10.1016/j.ejim.2015.07.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
45 Ferro JM, Oliveira Santos M. Neurology of inflammatory bowel disease. J Neurol Sci 2021;424:117426. [PMID: 33810878 DOI: 10.1016/j.jns.2021.117426] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Gondim Fde A, Oliveira GR, Teles BC, Souza MH, Braga LL, Messias EL. A case-control study of the prevalence of neurological diseases in inflammatory bowel disease (IBD). Arq Neuropsiquiatr 2015;73:119-24. [PMID: 25742581 DOI: 10.1590/0004-282X20140223] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 1.4] [Reference Citation Analysis]
47 Raftopoulos C, Koenig S, Joris V, Duprez T. Partial cauda equina syndrome after an uneventful minimally invasive microdiscectomy in a patient with Crohn's disease. Neurochirurgie 2017;63:21-4. [PMID: 28285756 DOI: 10.1016/j.neuchi.2016.10.007] [Reference Citation Analysis]
48 Jiang W, Luo Z, Stephenson S, Li H, Di Germanio C, Norris PJ, Fuchs D, Zetterberg H, Gisslen M, Price RW. Cerebrospinal Fluid and Plasma Lipopolysaccharide Levels in Human Immunodeficiency Virus Type 1 Infection and Associations With Inflammation, Blood-Brain Barrier Permeability, and Neuronal Injury. J Infect Dis 2021;223:1612-20. [PMID: 33320240 DOI: 10.1093/infdis/jiaa765] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
49 Waljee AK, Noureldin M, Berinstein JA, Cohen-Mekelburg SA, Wallace BI, Cushing KC, Hanauer DA, Keeney-Bonthrone TP, Nallamothu B, Higgins PDR. Mapping the relationships between inflammatory bowel disease and comorbid diagnoses to identify disease associations. Eur J Gastroenterol Hepatol 2020;32:1341-7. [PMID: 32804850 DOI: 10.1097/MEG.0000000000001869] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]